Digital x-ray developer Swissray International announced this month its plans to reorganize the company, although it declined to provide details of the restructuring. The company said restructuring was necessary as the firm moves from a development phase
Digital x-ray developer Swissray International announced this month its plans to reorganize the company, although it declined to provide details of the restructuring. The company said restructuring was necessary as the firm moves from a development phase into a product marketing phase. Swissray's AddOn-Multi-System received 510(k) clearance in December (SCAN 1/21/98). The New York City-based firm also said that it plans to immediately enter negotiations with a group of investors concerning a financing of the firm's short-term and medium-term capital needs.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.